Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer
| Autor: | Chang, Jianhua, Wu, Yi-Long, Lu, Shun, Wang, Jie, Mok, Tony, Zhang, Li, Feng, Jifeng, Wu, Lin, Tu, Hai-Yan, Zhang, Yiping, Luft, Alexander, Zhou, Jian-ying, Ma, Zhiyong, Lu, You, Hu, Chengping, Shi, Yuankai, Poddubskaya, Elena, Soo, Ross A., Chia, Yee Hong, Penrod, John R., Taylor, Fiona, Lawrance, Rachael, Blum, Steven I., Sun, Xiaowu, Juarez-Garcia, Ariadna, Moreno-Koehler, Alejandro, Li, Ang, Li, Amy, Cheng, Ying |
|---|---|
| Zdroj: | In Lung Cancer March 2022 165:71-81 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect